Stocks and Investing
Stocks and Investing
Thu, March 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (ATXS) at Strong Buy and Held Target at $18 on, Mar 14th, 2024
Joseph Pantginis of HC Wainwright & Co., Reiterated "Astria Therapeutics, Inc." (ATXS) at Strong Buy and Held Target at $18 on, Mar 14th, 2024.
Joseph has made no other calls on ATXS in the last 4 months.
There are 2 other peers that have a rating on ATXS. Out of the 2 peers that are also analyzing ATXS, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joseph
- Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $17 on, Tuesday, March 5th, 2024
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $25 on, Wednesday, November 15th, 2023
Contributing Sources